OTC drug labeling consumer comprehension to be discussed at Sept. 29 public hearing.
This article was originally published in The Tan Sheet
Executive Summary
OTC DRUG LABELING CONSUMER COMPREHENSION ISSUES TO BE DISCUSSED at a public hearing scheduled for Sept. 29 at FDA headquarters. The hearing is intended to solicit information and opinions on "various aspects of OTC drug labeling design that would improve the communication of information to consumers" and will examine whether consumers understand the information presented on OTC drug labels.